Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells
- PMID: 6199890
- DOI: 10.1016/0042-6822(84)90429-x
Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells
Abstract
The polycation DEAE-dextran increased the binding of VSV to BHK cells about fourfold over a wide range of VSV concentrations. The same proportion of bound virions was internalized by the cell in the presence or absence of DEAE-dextran. Viral primary RNA production was increased to the equivalent of a 4- to 4.5-fold increase in multiplicity of infection in the presence of DEAE-dextran, closely paralleling the increase in total VSV binding to the cell. Viral secondary RNA production was increased only to the equivalent of about twofold increase in multiplicity. The kinetics of both primary and secondary RNA production were indistinguishable in the presence or absence of DEAE-dextran. DEAE-dextran had to be present simultaneously with the input virions in order to enhance RNA production; addition even 30 min after infection was ineffective. Addition of the polycation DEAE-dextran was also required for appreciable VSV-induced hemolysis of human erythrocytes; erythrocytes of several other species were hemolyzed in the absence of DEAE-dextran, but hemolysis was enhanced by its presence. Maximal binding and hemolysis occurred at pH 5.0 and 37 degrees. Vesicles containing only G protein and viral lipid were 40% as hemolytic as intact virions at pH 5.0, but were inactive at pH 6.0; "spikeless" virions lacking G, or protein-free viral lipid vesicles were not hemolytic, showing that G protein is necessary for hemolysis. These results, together with other recent observations, suggest that multiple electrostatic interactions between VSV and the cell surface, rather than an affinity for specific surface molecules, mediated the productive (infection producing) binding of VSV to the cell surface.
Similar articles
-
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.J Virol. 1975 Jul;16(1):75-84. doi: 10.1128/JVI.16.1.75-84.1975. J Virol. 1975. PMID: 166210 Free PMC article.
-
Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection.J Cell Biol. 1980 Feb;84(2):421-9. doi: 10.1083/jcb.84.2.421. J Cell Biol. 1980. PMID: 6247354 Free PMC article.
-
Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.Virology. 1998 Jan 20;240(2):349-58. doi: 10.1006/viro.1997.8921. Virology. 1998. PMID: 9454708
-
DEAE-Dextran Transfection.Cold Spring Harb Protoc. 2018 Jul 2;2018(7). doi: 10.1101/pdb.top096263. Cold Spring Harb Protoc. 2018. PMID: 29967279 Review.
-
DEAE-dextran transfection of mammalian cultured cells.Methods Mol Biol. 2000;130:147-53. doi: 10.1385/1-59259-686-x:147. Methods Mol Biol. 2000. PMID: 10589428 Review. No abstract available.
Cited by
-
CARD8 inflammasome activation during HIV-1 cell-to-cell transmission.bioRxiv [Preprint]. 2025 Feb 15:2024.08.21.608981. doi: 10.1101/2024.08.21.608981. bioRxiv. 2025. Update in: Elife. 2025 Jun 16;13:RP102676. doi: 10.7554/eLife.102676. PMID: 39229127 Free PMC article. Updated. Preprint.
-
Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.Bioconjug Chem. 2015 Jan 21;26(1):71-7. doi: 10.1021/bc500408p. Epub 2014 Dec 30. Bioconjug Chem. 2015. PMID: 25547808 Free PMC article.
-
The cationic cytokine IL-26 differentially modulates virus infection in culture.PLoS One. 2013 Jul 10;8(7):e70281. doi: 10.1371/journal.pone.0070281. Print 2013. PLoS One. 2013. PMID: 23875025 Free PMC article.
-
CARD8 inflammasome activation during HIV-1 cell-to-cell transmission.Elife. 2025 Jun 16;13:RP102676. doi: 10.7554/eLife.102676. Elife. 2025. PMID: 40522834 Free PMC article.
-
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.Cancers (Basel). 2021 Mar 9;13(5):1171. doi: 10.3390/cancers13051171. Cancers (Basel). 2021. PMID: 33803211 Free PMC article. Review.